We aim to bring novel antibiotics and medicines for high medical needs to patients. Polyphor’s goal is to be the leader in the development of novel antibiotics and other efficacious therapies against specialty diseases with high medical needs.
Polyphor was founded in 1996 and is a clinical stage, privately held Swiss specialty pharma company, based in Allschwil near Basel. It focuses on the development of macrocycle drugs that address antibiotic resistance and severe respiratory diseases.
Location: United States, Indiana, York
Member count: 51-200
Phone: +41 61 567 16 00
Total raised: $39.796005M
Founded date: 1996
Investors 1
| Date | Name | Website |
| - | CARB-X | carb-x.org |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 16.04.2017 | - | $39.796005... | - | finsmes.co... |
Mentions in press and media 39
| Date | Title | Description | Category | Author | Source |
| 30.12.2021 | Polyphor c... | EQS-Ad-hoc: Polyphor AG / Key ... | - | - | marketscre... |
| 29.12.2021 | Polyphor t... | EQS-Ad-hoc: Polyphor AG / Key ... | - | - | marketscre... |
| 02.09.2021 | After setb... | Polyphor and Enbiotix have sig... | Financing ... | - | startuptic... |
| 16.07.2021 | Eli Lilly... | Neil Berkley → Covid-19 vari... | - | Kathy Wong... | endpts.com... |
| 16.07.2021 | JAK inhib... | Two more supplemental new d... | - | Zachary Br... | endpts.com... |
| 16.07.2021 | Nasdaq ri... | Editor’s note: Interested... | Financing | Josh Sulli... | endpts.com... |
| 16.07.2021 | Celulari... | It took a few months longer th... | - | Amber Tong | endpts.com... |
| 16.07.2021 | Pfizer se... | Pfizer has agreed to pay $345... | - | Zachary Br... | endpts.com... |
| 16.07.2021 | Alexion t... | A little less than a week be... | - | Max Gelman | endpts.com... |
| 16.07.2021 | Polyphor a... | Polyphor’s restructuring is... | - | Jason Mast | endpts.com... |
Show more